Latest news
Precigen: 'Strong Buy' Papzimeos Cash-Flow Breakeven In '26, PRGN-2009 Advancement (PGEN) - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 19:39:20 GMTPrecigen upgraded to Strong Buy on rising PAPZI... - PluangPluang · Thu, 06 Aug 2026 07:00:00 GMTGermantown biopharma Precigen turns first quarterly profit after key drug scores FDA approval - The Business JournalsThe Business Journals · Wed, 05 Aug 2026 19:25:00 GMTPGEN: PAPZIMEOS Q2 revenue soared 145% to $53.1M, driving profitability and rapid adoption - TradingViewTradingView · Tue, 04 Aug 2026 22:07:13 GMTPGEN: Q2 2026 marked first profitability, fueled by Papzimeos' strong commercial launch and revenue growth - TradingViewTradingView · Tue, 04 Aug 2026 20:17:10 GMTPGEN: Profitability reached as PAPZIMEOS drives record revenue and broad US adoption - TradingViewTradingView · Tue, 04 Aug 2026 20:11:03 GMTPrecigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth - PR NewswirePR Newswire · Tue, 04 Aug 2026 20:01:00 GMT